Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Elizabeth L Hougen. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Elizabeth L Hougen har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | EVP, Finance & CFO | 110 500 |
Chief Financial Officer | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Elizabeth L Hougen. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IONS / Ionis Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Elizabeth L Hougen som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 523 | 110 500 | −1,36 | 32,44 | −49 404 | 3 584 443 | |
2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 4 138 | 112 023 | 3,84 | ||||
2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 870 | 107 885 | −7,60 | 32,81 | −290 989 | 3 539 275 | |
2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 887 | 116 755 | 25,72 | ||||
2024-09-04 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 162 | 92 868 | −2,28 | 49,54 | −107 105 | 4 600 671 | |
2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 125 | 92 905 | −2,24 | 49,54 | −105 272 | 4 602 504 | |
2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 4 140 | 95 030 | 4,55 | ||||
2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 683 | 90 890 | −8,72 | 50,42 | −437 771 | 4 582 401 | |
2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 22 487 | 99 573 | 29,17 | ||||
2024-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −43 798 | 77 086 | −36,23 | 50,50 | −2 211 799 | 3 892 843 | |
2024-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 45 225 | 120 884 | 59,77 | 47,34 | 2 140 952 | 5 722 649 | |
2023-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 163 | 75 659 | 0,22 | 30,52 | 4 974 | 2 308 734 | |
2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 079 | 75 496 | −2,68 | 40,59 | −84 392 | 3 064 586 | |
2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 4 140 | 77 575 | 5,64 | ||||
2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 280 | 73 435 | −10,13 | 39,70 | −328 721 | 2 915 414 | |
2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 154 | 81 715 | 39,54 | ||||
2022-09-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 202 | 58 561 | 0,35 | 28,97 | 5 852 | 1 696 395 | |
2022-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 384 | 58 359 | 0,66 | 28,37 | 10 895 | 1 655 820 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −22 050 | 55 837 | −28,31 | ||||
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −7 828 | 57 975 | −11,90 | 30,12 | −235 779 | 1 746 207 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 22 050 | 65 803 | 50,40 | ||||
2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 16 559 | 77 887 | 27,00 | ||||
2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 12 419 | 12 419 | |||||
2022-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 33 118 | 33 118 | |||||
2021-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 166 | 43 753 | 0,38 | 33,80 | 5 610 | 1 478 676 | |
2021-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 116 | 43 587 | 0,27 | 44,54 | 5 167 | 1 941 365 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −17 151 | 34 199 | −33,40 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 27 129 | 27 129 | |||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −6 175 | 43 471 | −12,44 | 61,28 | −378 404 | 2 663 903 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 151 | 49 646 | 52,78 | ||||
2021-01-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 61 041 | 61 041 | |||||
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −21 680 | 0 | −100,00 | ||||
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 680 | 32 495 | −40,02 | 50,05 | −1 085 084 | 1 626 375 |
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 21 680 | 54 175 | 66,72 | 39,87 | 864 382 | 2 159 957 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 320 | 21 680 | −16,62 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 320 | 32 495 | −11,73 | 50,83 | −219 586 | 1 651 721 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 320 | 36 815 | 13,29 | 39,87 | 172 238 | 1 467 814 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 875 | 26 000 | −18,43 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 125 | 31 875 | −29,17 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 875 | 32 495 | −15,31 | 50,11 | −294 396 | 1 628 324 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 875 | 38 370 | 18,08 | 39,87 | 234 236 | 1 529 812 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 125 | 32 495 | −28,77 | 50,11 | −657 694 | 1 628 324 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 125 | 45 620 | 40,39 | 39,87 | 523 294 | 1 818 869 |
2020-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 121 | 32 495 | 0,37 | 44,46 | 5 379 | 1 444 565 | |
2020-03-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 147 | 32 374 | 0,46 | 43,16 | 6 345 | 1 397 359 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −12 044 | 24 550 | −32,91 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 26 800 | 26 800 | |||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −4 277 | 32 227 | −11,72 | 62,06 | −265 431 | 2 000 008 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 044 | 36 504 | 49,24 | ||||
2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 60 299 | 60 299 | |||||
2019-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 438 | 0 | −100,00 | ||||
2019-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 196 | 0 | −100,00 | ||||
2019-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −2 014 | 24 460 | −7,61 | 61,52 | −123 901 | 1 504 779 | |
2019-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 438 | 26 474 | 14,92 | 10,82 | 37 199 | 286 449 | |
2019-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −4 215 | 23 036 | −15,47 | 61,52 | −259 307 | 1 417 175 | |
2019-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 196 | 27 251 | 35,88 | 10,82 | 77 861 | 294 856 | |
2019-12-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 062 | 3 438 | −54,16 | ||||
2019-12-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −504 | 7 196 | −6,55 | ||||
2019-12-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 062 | 20 055 | −16,84 | 65,00 | −264 030 | 1 303 575 |
2019-12-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 062 | 24 117 | 20,25 | 10,82 | 43 951 | 260 946 |
2019-12-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −504 | 20 055 | −2,45 | 65,00 | −32 760 | 1 303 575 |
2019-12-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 504 | 20 559 | 2,51 | 10,82 | 5 453 | 222 448 |
2019-11-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 7 700 | −34,19 | ||||
2019-11-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 20 055 | −16,63 | 62,50 | −250 000 | 1 253 438 |
2019-11-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 24 055 | 19,95 | 10,82 | 43 280 | 260 275 |
2019-11-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 11 700 | −25,48 | ||||
2019-11-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 20 055 | −16,63 | 58,80 | −235 200 | 1 179 234 |
2019-11-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 24 055 | 19,95 | 10,82 | 43 280 | 260 275 |
2019-07-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 105 | 20 055 | 0,53 | 45,70 | 4 799 | 916 604 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −7 891 | 14 463 | −35,30 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 22 131 | 22 131 | |||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −2 842 | 19 823 | −12,54 | 58,26 | −165 575 | 1 154 888 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 891 | 22 665 | 53,41 | ||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 49 800 | 49 800 | |||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 127 | 14 901 | 0,86 | 36,45 | 4 629 | 543 112 | |
2018-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 2 063 | 0 | −100,00 | ||||
2018-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 063 | 14 774 | −12,25 | 52,05 | −107 379 | 768 987 |
2018-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 063 | 16 837 | 13,96 | 7,25 | 14 957 | 122 068 |
2018-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 2 000 | 2 063 | 3 174,60 | ||||
2018-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 14 774 | −11,92 | 52,00 | −104 000 | 768 248 |
2018-12-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 16 774 | 13,54 | 7,25 | 14 500 | 121 612 |
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 274 | 14 774 | 1,89 | 35,42 | 9 705 | 523 288 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 724 | 14 500 | −15,82 | 51,76 | −140 994 | 750 520 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 732 | 10 217 | −39,72 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 12 137 | 12 137 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 732 | 17 224 | 64,16 | ||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 54 619 | 54 619 | |||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 100 | 10 492 | 0,96 | 42,76 | 4 276 | 448 585 | |
2017-12-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2017-12-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 10 392 | −32,48 | 52,55 | −262 750 | 546 100 |
2017-12-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 392 | 48,11 | 10,29 | 51 450 | 158 384 |
2017-12-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 5 000 | −44,44 | ||||
2017-12-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 10 392 | −27,79 | 57,00 | −228 000 | 592 344 |
2017-12-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 14 392 | 38,49 | 10,29 | 41 160 | 148 094 |
2017-12-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 9 000 | −40,00 | ||||
2017-12-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 10 392 | −36,60 | 53,02 | −318 120 | 550 984 |
2017-12-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 16 392 | 57,74 | 10,29 | 61 740 | 168 674 |
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 000 | 15 000 | −31,82 | ||||
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 000 | 10 392 | −40,25 | 54,35 | −380 450 | 564 805 |
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 000 | 17 392 | 67,36 | 10,29 | 72 030 | 178 964 |
2017-07-13 | 3 | AKCA |
AKCEA THERAPEUTICS, INC.
No securities are beneficially owned. |
0 | ||||||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 104 | 10 392 | 1,01 | 40,66 | 4 228 | 422 492 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −623 | 10 288 | −5,71 | 46,29 | −28 839 | 476 232 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 9 317 | −5,47 | 46,29 | −24 951 | 431 293 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −733 | 8 476 | −7,96 | 46,29 | −33 931 | 392 354 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −256 | 7 334 | −3,37 | 46,29 | −11 850 | 339 491 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −122 | 6 937 | −1,73 | 46,29 | −5 648 | 321 135 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 594 | 4 779 | −25,01 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 380 | 2 758 | −33,35 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 1 875 | −50,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −653 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −312 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 537 | 7 537 | |||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 594 | 10 911 | 17,11 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 380 | 9 856 | 16,28 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 9 209 | 25,57 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 653 | 7 590 | 9,41 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 312 | 7 059 | 4,62 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 225 | 45 225 | |||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 199 | 6 747 | 3,04 | 20,76 | 4 131 | 140 047 | |
2016-12-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2016-12-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 6 548 | −27,63 | 46,05 | −115 125 | 301 535 |
2016-12-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 9 048 | 38,18 | 11,27 | 28 175 | 101 971 |
2016-11-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 2 500 | −50,00 | ||||
2016-11-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 6 548 | −27,63 | 47,50 | −118 750 | 311 030 |
2016-11-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 9 048 | 38,18 | 11,27 | 28 175 | 101 971 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 5 000 | −33,33 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 6 548 | −27,63 | 41,00 | −102 500 | 268 468 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 9 048 | 38,18 | 11,27 | 28 175 | 101 971 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 500 | 7 500 | −25,00 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 6 548 | −27,63 | 38,49 | −96 225 | 252 033 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 9 048 | 38,18 | 11,27 | 28 175 | 101 971 |
2016-07-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 217 | 6 548 | 3,43 | 20,76 | 4 504 | 135 917 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −550 | 6 331 | −7,99 | 41,47 | −22 806 | 262 519 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −747 | 5 501 | −11,96 | 41,47 | −30 975 | 228 105 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −261 | 4 373 | −5,63 | 41,46 | −10 822 | 181 319 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −125 | 3 980 | −3,05 | 41,46 | −5 182 | 165 003 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −216 | 3 793 | −5,39 | 41,47 | −8 957 | 157 279 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 380 | 4 138 | −25,01 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −1 875 | 3 750 | −33,33 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −654 | 653 | −50,04 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −312 | 312 | −50,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −541 | 0 | −100,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 373 | 6 373 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 380 | 6 881 | 25,09 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 6 248 | 42,88 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 654 | 4 634 | 16,43 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 312 | 4 105 | 8,23 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 541 | 4 009 | 15,60 | ||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 38 240 | 38 240 | |||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 41 | 3 468 | 1,20 | 47,71 | 1 956 | 165 460 | |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 40 | 3 427 | 1,18 | 48,59 | 1 943 | 166 504 | |
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | ||||
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 3 387 | −74,70 | 73,33 | −733 260 | 248 355 |
2015-03-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 13 387 | 295,25 | 11,27 | 112 700 | 150 871 |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 437 | 4 063 | −79,16 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −12 657 | 0 | −100,00 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 437 | 3 387 | −68,71 | 71,32 | −530 377 | 241 547 |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 437 | 10 824 | 219,57 | 7,25 | 53 918 | 78 474 |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 000 | 3 387 | −70,26 | 71,67 | −573 344 | 242 740 |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 000 | 11 387 | 236,20 | 7,25 | 58 000 | 82 556 |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 657 | 3 387 | −78,89 | 71,67 | −907 102 | 242 740 |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 657 | 16 044 | 373,69 | 14,47 | 183 147 | 232 157 |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −714 | 3 387 | −17,41 | 67,96 | −48 526 | 230 194 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −250 | 2 226 | −10,10 | 67,96 | −16 991 | 151 288 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −120 | 1 822 | −6,18 | 67,96 | −8 156 | 123 830 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −207 | 1 629 | −11,27 | 67,96 | −14 069 | 110 713 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 5 625 | −25,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −654 | 1 307 | −33,35 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −313 | 624 | −33,40 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −541 | 541 | −50,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 518 | 5 518 | |||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 4 101 | 84,23 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 654 | 2 476 | 35,89 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 313 | 1 942 | 19,21 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 541 | 1 836 | 41,78 | ||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 33 112 | 33 112 | |||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 63 | 1 295 | 5,11 | 30,05 | 1 893 | 38 912 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −120 | 1 232 | −8,88 | 47,08 | −5 650 | 58 002 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −207 | 1 039 | −16,61 | 47,08 | −9 746 | 48 916 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −250 | 704 | −26,21 | 47,08 | −11 770 | 33 144 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −313 | 937 | −25,04 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −542 | 1 082 | −33,37 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −654 | 1 961 | −25,01 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 500 | 7 500 | |||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 313 | 1 352 | 30,13 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 542 | 1 246 | 76,99 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 654 | 954 | 218,00 | ||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 000 | 45 000 | |||||
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 417 | 0 | −100,00 | ||||
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 417 | 300 | −97,20 | 22,38 | −233 132 | 6 714 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 417 | 10 717 | 3 472,33 | 15,38 | 160 213 | 164 827 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 813 | 10 417 | −42,86 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 843 | 12 657 | −43,75 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 300 | −86,96 | 21,43 | −42 860 | 6 429 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 2 300 | 666,67 | 15,38 | 30 760 | 35 374 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 300 | −90,91 | 21,41 | −64 230 | 6 423 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 300 | 1 000,00 | 15,38 | 46 140 | 50 754 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 813 | 300 | −90,36 | 21,40 | −60 198 | 6 420 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 813 | 3 113 | 937,67 | 15,38 | 43 264 | 47 878 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 843 | 300 | −97,04 | 21,49 | −211 526 | 6 447 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 843 | 10 143 | 3 281,00 | 14,47 | 142 428 | 146 769 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 792 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 584 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 792 | 300 | −94,11 | 18,13 | −86 879 | 5 439 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 792 | 5 092 | 1 597,33 | 11,12 | 53 287 | 56 623 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 584 | 300 | −96,96 | 18,13 | −173 758 | 5 439 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 584 | 9 884 | 3 194,67 | 11,12 | 106 574 | 109 910 |
2013-03-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 040 | 0 | −100,00 | ||||
2013-03-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 040 | 300 | −94,38 | 16,86 | −84 960 | 5 057 |
2013-03-07 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 340 | 1 680,00 | 6,81 | 34 322 | 36 365 |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −242 | 300 | −44,65 | 14,00 | −3 388 | 4 200 | |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 615 | 2 615 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 250 | 1 250 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −542 | 1 624 | −25,02 | ||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 542 | 542 | |||||
2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 15 700 | 15 700 | |||||
2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2013-01-03 | 3 | ISIS |
ISIS PHARMACEUTICALS INC
No securities are beneficially owned |
0 |